You are here

cognitrace™

cognitrace™

Straightforward recording and analysis of clinical EEG

EEG and cognitive evoked potentials may be used in the evaluation of certain psychiatric disorders. cognitrace provides you with a complete battery of tests that can be used in daily routine to discriminate between psychiatric and neurological diseases.

cognitrace applies dedicated recording hardware and analysis protocols for EEG and evoked potential (EP) data. Topographical maps of the spectral power of EEG and the event-related brain responses are linked with statistical information available for age-matched reference groups to gain objective data that help differentiating psychiatric from neurological cases.

Easy operation

The innovative click-and-go concept of cognitrace contributes to the efficiency of the system. Well-designed templates outline the workflow and lead you step-by-step through the recording, analysis and reporting. The intuitive displays for EEG traces, voltage and spectral maps are documented automatically into ready-to-print reports.

Complete turn-key solution

Patient management and administration are indispensable for a clinical system. cognitrace provides a smooth, network-wide user interface for the administration of patients, their recordings and reports. cognitrace is set up in a way that regular EEG and complex cognitive trials are combined in one session, which saves time and money.

Comprehensive cognitive tests

Audio-visual stimuli are presented to the patient while the system collects the corresponding brain waves through the scalp. The most common sessions include:

  • Spontaneous EEG Eyes open/closed condition, hyperventilation, photic flash stimulation: indication for possible neurological deficits.
  • Visual Evoked Potential (VEP) Response of the brains visual system.
  • Auditory Evoked Potential (AEP) Cortical (long latency) response of the auditory system.
  • Auditory oddball paradigm (P300) Capacity to process relevant and ignore irrelevant information, indicator for attention deficits of various forms.
  • Contingent Negative Variation (CNV) Response anticipation.
  • Mismatch Negativity (MMN)
  • P50 paradigm Inhibition of the brain to repeated information.

Request an offer >>

cognitrace is compliant with international standards for use in clinical environments. CE marked as a medical device in the EU, according to MDD 93/42/EEC, class IIa. Medical Device clearance under FDA 510(k); MDL issued by Health Canada.

© Copyright 1999 - 2018 ANT Neuro | www.ant-neuro.com | Terms of Use | Privacy Statement | Contact | USA Customers